Combined cognitive and motor training for people with stroke or Moyamoya disease
Official title: Impact of Cognitive-Motor Incorporated Training and Brain Activation Patterns in Cerebrovascular Diseases With Cognitive and Motor Impairments: Post Stroke Cognitive Impairment and Moyamoya Disease
Run by National Taiwan University Hospital · NCT07144930 · Data updated 2026-11-12
This trial will test whether combined cognitive-motor training helps people with post-stroke cognitive impairment or Moyamoya disease improve their thinking and movement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 100 Years |
| Sex | All |
| Enrollment | 210 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | June 23, 2025 |
| Main results expected | August 31, 2028 |
| Study ends | August 31, 2028 |
| Registry record updated | August 28, 2026 |
| Trial ID | NCT07144930 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 20 or older who can stand for at least 30 seconds, including people with a confirmed stroke (subacute or chronic) or confirmed Moyamoya disease with MoCA scores below 26, as well as age-matched healthy volunteers with MoCA above 26.
✕Probably not a fit
People with unstable or uncontrolled vital signs, those who cannot safely stand for 30 seconds, or patients with medical conditions that prevent safe participation are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project begins with a cross-sectional comparison of adults with post-stroke cognitive impairment, adults with Moyamoya disease, and age-matched healthy controls, with 30 participants in each group. All participants will undergo standardized cognitive tests (global cognition and executive function), motor tests (sensorimotor measures, single- and dual-task standing, strength, and walking), and brain activation imaging to map neural patterns. The aim is to characterize how cognitive and motor impairments relate to brain activation across these groups. These baseline data will inform the design and potential application of a motor-cognitive incorporated training (MCIT) intervention in subsequent parts of the project.
Why it matters
Potential benefit: If successful, this approach could lead to training programs that improve both thinking and movement in people with stroke-related cognitive problems or Moyamoya disease.
How similar studies have gone: Previous combined cognitive-motor rehabilitation programs have shown promise in improving cognition and dual-task mobility after stroke, but applying MCIT specifically to Moyamoya disease is largely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Part 1: Inclusion Criteria: * For aged-matched healthy controls: 1. being 20 years of age or older 2. the ability to stand for more than 30 seconds 3. a MoCA score of higher than 26. * For PSCI participants: 1. Diagnosis of stroke confirmed by brain CT or MRI, with symptom onset more than 7 days prior (subacute or chronic phase) 2. Being 20 years of age or older 3. The ability to stand for more than 30 seconds 4. a MoCA score of less than 26 * For the MMD group: 1. a confirmed diagnosis of Moyamoya disease or Moyamoya syndrome through CT scan or angiography 2. If stroke occurred, being in the subacute phase (one week post-stroke) 3. being 20 years of age or older 4. the ability to stand for more than 30 seconds 5. a MoCA score of less than 26 Exclusion Criteria: 1. unstable or uncontrolled vital signs, including a resting heart rate \>100 or \<40 BPM, a respiratory rate \>20 or \<12 breaths per minute, an SpO2 \< 95%, a central arterial pressure (CAP) \<80 mmHg, and individuals requiring ICP monitoring will also be excluded 2. requiring invasive mechanical ventilation or being deemed unsuitable by the attending physician due to unstable medical conditions 3. the presence of other neurological disorders or unstable vital signs may interfere with the experiment 4. currently hospitalized in the intensive care unit (ICU) 5. Severe visual or hearing impairments, or communication and comprehension difficulties that interfere with study participation Part 2: Inclusion Criteria: 1. Diagnosis of stroke confirmed by brain CT or MRI, with symptom onset more than 7 days prior (subacute or chronic phase) 2. Being 20 years of age or older 3. The ability to stand for more than 30 seconds 4. a MoCA score of less than 26 Exclusion Criteria: 1. unstable or uncontrolled vital signs, including a resting heart rate \>100 or \<40 BPM, a respiratory rate \>20 or \<12 breaths per minute, an SpO2 \< 95%, a central arterial pressure (CAP) \<80 mmHg, and individuals requiring ICP monitoring will also be excluded 2. requiring invasive mechanical ventilation or being deemed unsuitable by the attending physician due to unstable medical conditions 3. the presence of other neurological disorders or unstable vital signs may interfere with the experiment 4. currently hospitalized in the intensive care unit (ICU) 5. Severe visual or hearing impairments, or communication and comprehension difficulties that interfere with study participation Part 3: Inclusion Criteria: 1. Moyamoya disease/syndrome confirmed through CT scan or angiography 2. being in the subacute phase, defined as one week after stroke onset 3. being 20 years of age or older 4. the ability to stand for more than 30 seconds 5. a Montreal Cognitive Assessment (MoCA) score of less than 26. Exclusion Criteria: 1. unstable or uncontrolled vital signs, including a resting heart rate \>100 or \<40 BPM, a respiratory rate \>20 or \<12 breaths per minute, an SpO2 \< 95%, a central arterial pressure (CAP) \<80 mmHg, and individuals requiring ICP monitoring will also be excluded 2. requiring invasive mechanical ventilation or being deemed unsuitable by the attending physician due to unstable medical conditions 3. the presence of other neurological disorders or unstable vital signs that could interfere with the experiment 4. currently hospitalized in the intensive care unit (ICU) 5. Severe visual or hearing impairments, or communication and comprehension difficulties that interfere with study participation.
Where it's running
-
National Taiwan University
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Yan Ci Liu, PhD — National Taiwan University
- Study coordinator: Yan Ci Liu, PhD
- Email: yanciliu@ntu.edu.tw
- Phone: +886233668135
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
5T MRI and Metabolomics to Predict Hemorrhage Risk in Moyamoya Disease
This study tests whether advanced 5T MRI imaging and metabolomics can help predict which moyamoya patients are at higher risk of intracranial hemorrhage.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Using a digital twin app to support people in secondary prevention after stroke, Moyamoya disease, or cerebral amyloid angiopathy
This trial will try the STRATIF-AI app plus usual secondary prevention care to see if it improves daily self-care and the patient experience for adults after stroke, Moyamoya disease, or CAA.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.